Birgit Girshick - 29 Jan 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Reporting relationship: Corporate Executive VP & COO
Issuer ticker: CRL
Reported as of: 29 Jan 2024
Net transaction value: -$255,305
SEC form: 4
Accepted by SEC: 31 Jan 2024, 19:14:00 UTC
Prior SEC filing: 11 Jan 2024
Next SEC filing: 16 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 31 Jan 2024.

Key facts

This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 31 Jan 2024, 19:14.

Change

Previous filing in this sequence was filed on 11 Jan 2024.
Current net transaction value: -$255,305.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Award

Transaction value: $0
Shares: +3,526
Change %: +7.7%
Price: $0.000000
Shares after: 49,274
Date: 29 Jan 2024
Ownership: Direct
Footnotes: F1

CRL transaction

Common Stock

Tax liability

Transaction value: $255,305
Shares: -1,159
Change %: -2.4%
Price: $220.28
Shares after: 48,115
Date: 29 Jan 2024
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021.